This article is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs requiring evaluation by a licensed healthcare professional. Eligibility is not guaranteed. Pricing information reflects published rates at time of writing and is subject to change. This article contains affiliate links.
Why Most “Best GLP-1 Programs” Lists Are Useless
I've read through a lot of these comparison articles while building out my research on this category, and most of them have the same problem: they rank programs based on who's paying the highest affiliate rate, not on what's actually relevant to a patient trying to make a decision in 2026.
The GLP-1 telehealth market has also changed significantly in the last eighteen months. When the FDA resolved the semaglutide and tirzepatide drug shortages in 2024 and early 2025, the regulatory ground shifted under the compounded GLP-1 industry. Any comparison article that doesn't account for that shift is working from an outdated map.
This article is structured differently. Instead of ranking platforms, I'm going to give you the framework for evaluating them yourself — the actual questions that matter, the categories that describe the landscape, and where the different programs fit. Then I'll tell you where my research points for specific situations.
The Four Categories of GLP-1 Programs in 2026
Category 1: Compounded GLP-1 Platforms (Cash-Pay Entry) — These are telehealth platforms offering compounded semaglutide or tirzepatide at lower price points than FDA-approved brand-name options. Examples include Wellorithm ($147/month entry for semaglutide), Hims (approximately $199/month at time of research), Ro, MEDVi, and others. These programs involve the same three-entity structure: technology platform, independent licensed clinicians, partner compounding pharmacies. The medications are not FDA-approved finished products. The regulatory landscape for these programs has tightened since the shortage ended.
Category 2: FDA-Approved Brand-Name Programs — Programs offering Wegovy (semaglutide), Zepbound (tirzepatide), or Foundayo (orforglipron, approved in 2025) — medications that have undergone the FDA's full drug approval process. These typically cost more without insurance but carry a different risk/benefit profile than compounded options. Platforms like WeightWatchers Clinic, GoodRx for Weight Loss, and Lemonaid Health work within this category. Some, like Ro, offer pathways to both compounded and FDA-approved options within the same program.
Category 3: Comprehensive Obesity Medicine Programs — Physician-led programs specifically designed for patients with clinical obesity as a primary medical diagnosis. Form Health and Calibrate are examples. These programs typically involve board-certified obesity medicine specialists, more intensive clinical oversight, nutritional coaching, and behavioral support alongside medication. They are generally more expensive and designed for patients who need more than a prescription and a shipping address.
Category 4: GLP-1 Support Supplements (Non-Prescription) — Non-prescription dietary supplements marketed to support natural metabolic function using terms like “GLP-1 support.” These are a completely different product category — not pharmaceutical receptor agonists, not prescription medications. My review of one such product covers this in detail: Sprout Health GLP-1 Supplement Review. For readers deciding between a supplement and a telehealth program, that distinction is the most important thing to understand.
The Five Questions That Actually Matter
1. Compounded or FDA-approved? This is the foundational question in 2026. Compounded is generally cheaper but carries different regulatory standing and a different risk profile post-shortage. FDA-approved is more expensive without insurance but comes with the full approval framework. Neither is automatically better — the right answer depends on your situation and what a licensed clinician determines is appropriate for you.
2. What is the specific program's regulatory standing in 2026? The compounding rules have changed since the shortages resolved. Before enrolling in any compounded program, ask directly: Is the pharmacy operating within current FDA post-shortage guidance? Is this a 503A (patient-specific) or 503B (outsourcing facility) pharmacy? The platform's support team and your prescribing clinician should be able to answer this.
3. What does the billing actually say? Marketing pages describe programs. Terms of service describe the actual deal. Wellorithm's billing terms indicate payments are non-refundable once processed — no money-back guarantee in the available documentation. Some programs have similar policies. Know what you're agreeing to before the first charge hits.
4. What level of clinical oversight does your situation require? For generally healthy adults with straightforward eligibility, a standard telehealth intake may be sufficient. For patients with complex medical history, multiple medications, or prior medical conditions, a program with more intensive clinical oversight is worth the additional cost.
5. What is the platform's independent review footprint? Established platforms like Hims and Ro have years of Trustpilot reviews, Reddit threads, and BBB records. Newer entrants may not. A thin or absent independent review record isn't automatically a red flag — it may just mean the platform is newer — but it's a signal to do more direct due diligence before enrolling.
Where My Research Points by Situation
If budget is primary and you understand the compounded landscape: Wellorithm at $147/month for compounded semaglutide is one of the lower entry points available. Understand the billing terms, verify the pharmacy, and know the regulatory context before signing up. My full review: Wellorithm Review 2026.
If you want a larger established platform with more independent review data: Hims and Ro are more established in this category. Ro has the added advantage of a clear pathway to FDA-approved medications within the same program relationship — relevant if the regulatory picture for compounded products continues to evolve.
If you want FDA-approved medication with insurance support: WeightWatchers Clinic and Lemonaid Health actively work with insurance for brand-name GLP-1 access. GoodRx for Weight Loss is positioned for cash-pay brand-name access.
If you have complex medical history or want a physician-specialized program: Form Health and Calibrate are designed for that use case. These are not direct Wellorithm competitors — they're a different category for patients who need more than a prescription.
If you want physician-supervised metabolic optimization that isn't specifically GLP-1 focused: My Maximus review covers that category — Maximus Review: Physician-Led Hormone and Metabolic Optimization.
Where Supplements Fit (and Don't)
For the readers who came to this article from my gelatin trick or supplement research: GLP-1 telehealth programs and GLP-1 supplements are not interchangeable. They are different products in different regulatory categories targeting different patient populations. Supplements like Sprout Health GLP-1 or MetaTrim BHB are not pharmaceutical receptor agonists — they cannot replicate the mechanism or the magnitude of prescription GLP-1 therapy. If you are a candidate for prescription GLP-1 therapy based on your BMI and health history, a supplement is not a substitute. If you are not a candidate, or if you prefer to try non-prescription options first, that's a different conversation. But the substitution comparison isn't a valid one.
For a comparison of GLP-1 telehealth platforms specifically against each other, see: Wellorithm vs. Hims and Ro: Comparing Compounded GLP-1 Telehealth Programs in 2026.
Frequently Asked Questions
What is the cheapest GLP-1 telehealth program in 2026?
Among compounded programs, Wellorithm's published starting price of $147/month for compounded semaglutide is one of the lower entry points at the time of this writing. Price must be weighed against program structure, regulatory standing, and billing terms — a lower price with a no-refund policy and limited independent review record carries different risk than a higher price from an established platform with insurance support.
Are GLP-1 telehealth programs covered by insurance?
FDA-approved brand-name GLP-1 medications may be covered by some insurance plans depending on diagnosis and plan. Compounded programs are typically cash-pay. Platforms like Ro and WeightWatchers Clinic actively assist with insurance navigation for FDA-approved options. Confirm your specific situation with the platform before enrolling.
What is the difference between compounded and FDA-approved GLP-1 programs?
FDA-approved GLP-1 medications have undergone the FDA's full drug approval process. Compounded formulations are prepared by licensed pharmacies based on individual prescriptions and have not been reviewed or approved by the FDA for safety, effectiveness, or quality. The two categories are not interchangeable legally or clinically.
Leave a Reply
You must be logged in to post a comment.